Year-end Trading Update

RNS Number : 9299M
Surgical Innovations Group PLC
14 January 2019
 

 

Surgical Innovations Group plc

("Surgical Innovations" or the "Group")

 

Year-end Trading Update

 

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, provides an update on trading for the year ended 31 December 2018.

 

Trading was significantly stronger in the second half of the year, resulting in Group revenue for the full year of approximately £11.0m. This represents growth of approximately 25% over 2017, with underlying revenue growth (adjusted for the effect of the acquisition of Elemental Healthcare Limited in August 2017) of approximately 8%.  Gross margin was within target range and the resulting increase in profit before tax is anticipated to be in line with Board expectations and market consensus.

 

The Group continued to be cash generative, with closing net cash balances of approximately £0.36m, compared with net debt at the start of the year of £0.73m.

 

Audited results for the year ended 31 December 2018 will be released in mid-March 2019.

 

For further information contact:

 

Surgical Innovations Group Plc

www.sigroupplc.com

Nigel Rogers, Executive Chairman

Tel: +44 (0)113 230 7597

Melanie Ross, COO and CFO




Walbrook PR (Financial PR & Investor Relations)

Tel: +44 (0)20 7933 8780 or si@walbrookpr.com

Paul McManus

Mob: +44 (0)7980 541 893

Lianne Cawthorne

Mob: +44 (0)7584 391 303



N+1 Singer (Nominated Adviser and Broker)

+44 (0)20 7496 3000

Richard Lindley


Rachel Hayes


 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFUFMFFUSELF
UK 100

Latest directors dealings